Cargando…

The Impact of Kinase Insert Domain (KDR) Gene Polymorphism rs2305948 on Clopidogrel Resistance in Iraqi Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

INTRODUCTION: Clopidogrel, the first-choice antiplatelet agent for patient undergoing Percutaneous Coronary Intervention (PCI) along with Aspirin. Clopidogrel resistance is one of the major obstacles that cause MACE and failure of PCI. Kinase Insert Domain (KDR) gene responsible for VEGFR2 coding, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahmed, Ali A., Amber, Khalid I., Hadi, Najah R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Medical sciences 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780779/ https://www.ncbi.nlm.nih.gov/pubmed/33417661 http://dx.doi.org/10.5455/aim.2020.28.202-208

Ejemplares similares

Association of KDR rs1870377 genotype with clopidogrel resistance in patients with post percutaneous coronary intervention
por: Al Awaida, Wajdy, et al.
Publicado: (2021)

Association of the VEGFR2 single nucleotide polymorphism rs2305948 with glioma risk
por: Sun, Shushu, et al.
Publicado: (2022)

Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention
por: Habibi, Zarina, et al.
Publicado: (2023)

Ticagrelor versus Clopidogrel in Patients with Severe Renal Insufficiency Undergoing PCI for Acute Coronary Syndrome
por: Chen, Yunxian, et al.
Publicado: (2022)

Treatment Outcomes of Clopidogrel in Patients With ACS and Diabetes Undergoing PCI-Analysis of Beijing Municipal Medical Insurance Database
por: Wang, Weihao, et al.
Publicado: (2021)

Efficacy and Safety Profile of Ticagrelor Versus Clopidogrel in Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome (ACS): A Systematic Review and Meta-Analysis
por: Maqbool, Shahzaib, et al.
Publicado: (2023)

Comparison of Ticagrelor and Clopidogrel for Patients Undergoing Emergency Percutaneous Coronary Intervention
por: YANG, Bin, et al.
Publicado: (2018)

Identification of vascular endothelial growth factor in preeclampsia in Iraqi women
por: Al-Ghazali, Basima, et al.
Publicado: (2022)

Platelet reactivity unit (PRU) in patients undergoing elective PCI: Rethinking the optimal cut point
por: Sharifi, Hassan, et al.
Publicado: (2017)

Antiatherosclerotic Potential of Clopidogrel: Antioxidant and Anti-Inflammatory Approaches
por: Hadi, Najah R., et al.
Publicado: (2013)

Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI)
por: Chen, Shuxia, et al.
Publicado: (2017)

Barriers to Early Discharge after Elective Percutaneous Coronary Intervention (BED PCI): A Single-Center Study
por: Graziano, Francis D., et al.
Publicado: (2017)

Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry
por: Völz, Sebastian, et al.
Publicado: (2020)

Safety and Efficacy Evaluation of Antithrombotic Therapy with Rivaroxaban and Clopidogrel After PCI in Chinese Patients
por: Bai, Long, et al.
Publicado: (2022)

Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Norgard, Nicholas B, et al.
Publicado: (2009)

The Impact of Clopidogrel Resistance on Clinical Outcome of Iranian Patients Undergoing Percutaneous Coronary Intervention
por: Haji Aghajani, Mohammad, et al.
Publicado: (2018)

Stress as a possible cause of a high incidence of hypertension and diabetes and a low incidence of asthma in the Iraqi population
por: Al-Isawi, Zahraa, et al.
Publicado: (2023)

Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI
por: Yamamoto, Ko, et al.
Publicado: (2023)

Pharmacodynamic Effect of Cilostazol Plus Standard Clopidogrel Versus Double-Dose Clopidogrel in Patients With Type 2 Diabetes Undergoing Percutaneous Coronary Intervention
por: Jeong, Young-Hoon, et al.
Publicado: (2012)

Transthyretin Gene Mutation Associated with Familial Carpal Tunnel Syndrome in Sample of Iraqi Patients
por: Al-Mudhafar, Rihab H., et al.
Publicado: (2021)

Evaluation of safety and efficacy of elective PCI in patients with cardiac insufficiency
por: Jing, Jiang-Xin, et al.
Publicado: (2017)

Association of kinase insert domain-containing receptor (KDR) gene polymorphism/ haplotypes with recurrent spontaneous abortion and genetic structure
por: Shahsavari, Shiva, et al.
Publicado: (2015)

Clinical characteristics associated with high on-treatment platelet reactivity of patients undergoing PCI after a 300 mg loading dose of clopidogrel, measured by thrombelastography
por: Hou, Xu-Min, et al.
Publicado: (2013)

Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
por: Wang, Zhe, et al.
Publicado: (2020)

Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
por: Krishnamurthy, Arvindra, et al.
Publicado: (2019)

Aspirin in combination with clopidogrel in the treatment of acute myocardial infarction patients undergoing percutaneous coronary intervention
por: Zhang, Xiaoyan, et al.
Publicado: (2019)

Effects of Ticagrelor versus Clopidogrel in Patients with Coronary Bifurcation Lesions Undergoing Percutaneous Coronary Intervention
por: Zheng, Wei, et al.
Publicado: (2019)

Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022)

Mechanical circulatory support devices for elective percutaneous coronary interventions: novel insights from the Japanese nationwide J-PCI registry
por: Muramatsu, Takashi, et al.
Publicado: (2022)

The clinical effect of nicorandil on perioperative myocardial protection in patients undergoing elective PCI: A Systematic Review and Meta-Analysis
por: Ye, Ziliang, et al.
Publicado: (2017)

Prevalence of clOpidogrel ‘resIstaNce’ in a selected population of patients undergoing elective percutaneous coronary intervention at a tertiary cardiovascular centre in Trinidad: the POINT pilot study
por: Seecheran, Naveen Anand, et al.
Publicado: (2019)

Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention
por: Bergmeijer, Thomas O., et al.
Publicado: (2020)

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban
por: Campo, Gianluca, et al.
Publicado: (2010)

Correction: Real-world comparison of clopidogrel, prasugrel and ticagrelor in patients undergoing primary percutaneous coronary intervention
Publicado: (2019)

Association of ABCB1 Gene Polymorphisms and Clopidogrel Responsiveness in Iranian Patients undergoing Percutaneous Coronary Intervention
por: Namazi, Soha, et al.
Publicado: (2020)

Efficacy and Safety of Ticagrelor and Clopidogrel in Patients with Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Jianan, et al.
Publicado: (2021)

Measuring depression and anxiety prevalence among Iraqi healthcare college students using hospital anxiety and depression scale
por: Kathem, Sarmed H., et al.
Publicado: (2021)

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability but Is Associated with Clinical Outcome after PCI
por: Park, Kyung Woo, et al.
Publicado: (2013)

An X-STRs analysis of the Iraqi Sorani Kurds
por: M. Albarzinji, Balnd, et al.
Publicado: (2023)

Genetic Polymorphism of CYP2C19 and Inhibitory Effects of Ticagrelor and Clopidogrel Towards Post-Percutaneous Coronary Intervention (PCI) Platelet Aggregation in Patients with Acute Coronary Syndromes
por: Dong, Peng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7dqcuve9evd9q5tvvrbrauopsg